Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Lichterfeld

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Journal of Virology|June 15, 2004
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infectionTodd M Allen, Marcus Altfeld, Xu G Yu, et al.
Journal of Virology|November 24, 2006
Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypesXu G Yu, Mathias Lichterfeld, Senica Chetty, et al.
Cell Reports|July 20, 2022
Immune correlates of HIV-1 reservoir cell decline in early-treated infantsCiputra Adijaya Hartana, Pilar Garcia-Broncano, Yelizaveta Rassadkina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine Vibholm, Mariane H Schleimann, Jesper F Højen, et al.
Cell Reports|June 10, 2023
Extrafollicular IgD<sup>-</sup>CD27<sup>-</sup>CXCR5<sup>-</sup>CD11c<sup>-</sup> DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19Hugues Allard-Chamard, Naoki Kaneko, Alice Bertocchi, et al.
The Journal of Clinical Investigation|July 20, 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollersRadwa Sharaf, Guinevere Q Lee, Xiaoming Sun, et al.
The Journal of Clinical Investigation|February 16, 2026
Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young childrenAischa Niesar, Melanie Lancien, Seohyun Hong, et al.
Nature Immunology|December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopesNicole Frahm, Photini Kiepiela, Sharon Adams, et al.
Eclinicalmedicine|December 13, 2021
Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivoNathan W Cummins, Jason Baker, Rana Chakraborty, et al.
Cell Host & Microbe|January 3, 2023
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapyXiaodong Lian, Kyra W Seiger, Elizabeth M Parsons, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Journal of Virology|June 15, 2004
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infectionTodd M Allen, Marcus Altfeld, Xu G Yu, et al.
Journal of Virology|November 24, 2006
Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypesXu G Yu, Mathias Lichterfeld, Senica Chetty, et al.
Cell Reports|July 20, 2022
Immune correlates of HIV-1 reservoir cell decline in early-treated infantsCiputra Adijaya Hartana, Pilar Garcia-Broncano, Yelizaveta Rassadkina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine Vibholm, Mariane H Schleimann, Jesper F Højen, et al.
Cell Reports|June 10, 2023
Extrafollicular IgD<sup>-</sup>CD27<sup>-</sup>CXCR5<sup>-</sup>CD11c<sup>-</sup> DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19Hugues Allard-Chamard, Naoki Kaneko, Alice Bertocchi, et al.
The Journal of Clinical Investigation|July 20, 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollersRadwa Sharaf, Guinevere Q Lee, Xiaoming Sun, et al.
The Journal of Clinical Investigation|February 16, 2026
Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young childrenAischa Niesar, Melanie Lancien, Seohyun Hong, et al.
Nature Immunology|December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopesNicole Frahm, Photini Kiepiela, Sharon Adams, et al.
Eclinicalmedicine|December 13, 2021
Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivoNathan W Cummins, Jason Baker, Rana Chakraborty, et al.
Cell Host & Microbe|January 3, 2023
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapyXiaodong Lian, Kyra W Seiger, Elizabeth M Parsons, et al.
Pageof 17